Skip to main navigation Skip to search Skip to main content

Three lessons for the COVID-19 response from pandemic HIV

  • James Hargreaves
  • , Calum Davey
  • , Judith Auerbach
  • , Jamie Blanchard
  • , Virginia Bond
  • , Chris Bonell
  • , Rochelle Burgess
  • , Joanna Busza
  • , Tim Colbourn
  • , Frances Cowan
  • , Aoife Doyle
  • , James Hakim
  • , Bernadette Hensen
  • , Mina Hosseinipour
  • , Leesa Lin
  • , Saul Johnson
  • , Nyasha Masuka
  • , Webster Mavhu
  • , Owen Mugurungi
  • , Solomon Mukungunugwa
  • Angela Mushavi, Andrew Phillips, Lucy Platt, Audrey Prost, Eugene Ruzagira, Janet Seeley, Isaac Taramusi, Raymond Yekeye
  • London School of Hygiene and Tropical Medicine

Research output: Contribution to journalArticlepeer-review

92 Citations (Scopus)

Abstract

The HIV pandemic provides lessons for the response to the novel coronavirus disease 2019 (COVID-19) pandemic: no vaccine is available for either and there are no licensed pharmaceuticals for COVID-19, just as there was not for HIV infection in the early years. Population behaviour will determine the pandemic trajectory of COVID-19,1 just as it did for HIV.

Original languageEnglish
Pages (from-to)e309-e311
JournalThe Lancet HIV
Volume7
Issue number5
Early online date13 Apr 2020
DOIs
Publication statusPublished - 1 May 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Three lessons for the COVID-19 response from pandemic HIV'. Together they form a unique fingerprint.

Cite this